Miguel García-Sanz - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Archivos Espanoles De Urologia|January 17, 2018

[Job status after the resident training period in Spain. Analysis of a national survey.]Miguel García Sanz, Moises Rodríguez Socarrás, Leonardo Tortolero Blanco, et al.

Archivos Espanoles De Urologia|January 17, 2018

[The role of social media in academic training in Urology. Adequate use.]Juan Gómez Rivas, Leonardo Tortolero Blanco, Moises Rodríguez Socarras, et al.

Revista Espanola De Salud Publica|January 21, 2016

[Hospital incidence, trends and municipal distribution of prostate cancer in health area of León, Spain (1996-2010)]Vicente Martín Sánchez, Miguel García-Sanz, Lidia García-Martínez, et al.

European Urology Open Science|October 30, 2024

Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world DatabaseMario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, et al.

The Prostate|September 4, 2025

Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With ApalutamideChristian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Archivos Espanoles De Urologia|January 17, 2018

[Job status after the resident training period in Spain. Analysis of a national survey.]Miguel García Sanz, Moises Rodríguez Socarrás, Leonardo Tortolero Blanco, et al.

Archivos Espanoles De Urologia|January 17, 2018

[The role of social media in academic training in Urology. Adequate use.]Juan Gómez Rivas, Leonardo Tortolero Blanco, Moises Rodríguez Socarras, et al.

Revista Espanola De Salud Publica|January 21, 2016

[Hospital incidence, trends and municipal distribution of prostate cancer in health area of León, Spain (1996-2010)]Vicente Martín Sánchez, Miguel García-Sanz, Lidia García-Martínez, et al.

European Urology Open Science|October 30, 2024

Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world DatabaseMario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, et al.

The Prostate|September 4, 2025

Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With ApalutamideChristian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, et al.

Pageof 1